คำถามที่พบบ่อย

What is Bulevirtide Acetate used for?

An entry inhibitor used to treat chronic hepatitis delta virus infection in adults with compensated liver disease. It works by blocking the sodium taurocholate cotransporting polypeptide receptor that the hepatitis D virus uses to enter liver cells. It is the first approved therapy specifically targeting hepatitis delta.

Is Bulevirtide Acetate an approved drug?

Yes, Bulevirtide Acetate is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

• ChEMBL — European Bioinformatics Institute (EBI). CHEMBL5315080. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.